-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Adma Biologics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2016 to Q4 2024.
- Adma Biologics, Inc. Amortization of Intangible Assets for the quarter ending December 31, 2024 was $25K, a 86.6% decline year-over-year.
- Adma Biologics, Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2024 was $388K, a 46.4% decline year-over-year.
- Adma Biologics, Inc. annual Amortization of Intangible Assets for 2024 was $388K, a 46.4% decline from 2023.
- Adma Biologics, Inc. annual Amortization of Intangible Assets for 2023 was $724K, a 1.26% increase from 2022.
- Adma Biologics, Inc. annual Amortization of Intangible Assets for 2022 was $715K, unchanged from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)